These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 21392178)

  • 1. Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats.
    Bito-Onon JJ; Simms JA; Chatterjee S; Holgate J; Bartlett SE
    Addict Biol; 2011 Jul; 16(3):440-9. PubMed ID: 21392178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice.
    Kamens HM; Andersen J; Picciotto MR
    Psychopharmacology (Berl); 2010 Mar; 208(4):613-26. PubMed ID: 20072781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial agonists of the α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats.
    Chatterjee S; Steensland P; Simms JA; Holgate J; Coe JW; Hurst RS; Shaffer CL; Lowe J; Rollema H; Bartlett SE
    Neuropsychopharmacology; 2011 Feb; 36(3):603-15. PubMed ID: 21048701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking.
    Steensland P; Simms JA; Holgate J; Richards JK; Bartlett SE
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12518-23. PubMed ID: 17626178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain.
    Hussmann GP; Turner JR; Lomazzo E; Venkatesh R; Cousins V; Xiao Y; Yasuda RP; Wolfe BB; Perry DC; Rezvani AH; Levin ED; Blendy JA; Kellar KJ
    J Pharmacol Exp Ther; 2012 Nov; 343(2):441-50. PubMed ID: 22899752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration.
    George O; Lloyd A; Carroll FI; Damaj MI; Koob GF
    Psychopharmacology (Berl); 2011 Feb; 213(4):715-22. PubMed ID: 20924754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control.
    Wouda JA; Riga D; De Vries W; Stegeman M; van Mourik Y; Schetters D; Schoffelmeer AN; Pattij T; De Vries TJ
    Psychopharmacology (Berl); 2011 Jul; 216(2):267-77. PubMed ID: 21331520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.
    Spiller K; Xi ZX; Li X; Ashby CR; Callahan PM; Tehim A; Gardner EL
    Neuropharmacology; 2009 Jul; 57(1):60-6. PubMed ID: 19393252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats.
    O'Connor EC; Parker D; Rollema H; Mead AN
    Psychopharmacology (Berl); 2010 Feb; 208(3):365-76. PubMed ID: 19967529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats.
    Scuppa G; Cippitelli A; Toll L; Ciccocioppo R; Ubaldi M
    Drug Alcohol Depend; 2015 Nov; 156():126-132. PubMed ID: 26383997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
    Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens.
    Feduccia AA; Simms JA; Mill D; Yi HY; Bartlett SE
    Br J Pharmacol; 2014 Jul; 171(14):3420-31. PubMed ID: 24628360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration.
    Mello NK; Fivel PA; Kohut SJ; Carroll FI
    Neuropsychopharmacology; 2014 Apr; 39(5):1222-31. PubMed ID: 24304823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.
    Hussmann GP; DeDominicis KE; Turner JR; Yasuda RP; Klehm J; Forcelli PA; Xiao Y; Richardson JR; Sahibzada N; Wolfe BB; Lindstrom J; Blendy JA; Kellar KJ
    J Neurochem; 2014 May; 129(4):721-31. PubMed ID: 24422997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats.
    Maggio SE; Saunders MA; Baxter TA; Nixon K; Prendergast MA; Zheng G; Crooks P; Dwoskin LP; Slack RD; Newman AH; Bell RL; Bardo MT
    Psychopharmacology (Berl); 2018 May; 235(5):1439-1453. PubMed ID: 29455292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic acetylcholine receptors containing the α4 subunit are critical for the nicotine-induced reduction of acute voluntary ethanol consumption.
    Hendrickson LM; Gardner P; Tapper AR
    Channels (Austin); 2011; 5(2):124-7. PubMed ID: 21239887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats.
    LeSage MG; Shelley D; Ross JT; Carroll FI; Corrigall WA
    Pharmacol Biochem Behav; 2009 Jan; 91(3):461-7. PubMed ID: 18817808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of varenicline on ethanol- and food-maintained responding in a concurrent access procedure.
    Ginsburg BC; Lamb RJ
    Alcohol Clin Exp Res; 2013 Jul; 37(7):1228-33. PubMed ID: 23413834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.
    Cunningham CS; McMahon LR
    Eur J Pharmacol; 2011 Mar; 654(1):47-52. PubMed ID: 21172344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sensitizing effect of acute nicotine on amphetamine-stimulated behavior and dopamine efflux requires activation of β2 subunit-containing nicotinic acetylcholine receptors and glutamate N-methyl-D-aspartate receptors.
    Kim MN; Jutkiewicz EM; Zhang M; Gnegy ME
    Neuropharmacology; 2011 Jun; 60(7-8):1126-34. PubMed ID: 20971124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.